Day 2 at ASCO 2026: Fresh Data from BioNTech‑Pfizer, Kelun, Merck and Insights from Dr. Pazdur The Unbearable Price of Hope A New Dawn for Bladder Cancer Patients: Astellas & Pfizer's Combination Therapy Halves Mortality Risk The Dawn of a New Era: Keytruda's Patent Cliff and the Future of Cancer Care